Communications Biology (Feb 2023)
Proteogenomics decodes the evolution of human ipsilateral breast cancer
- Tommaso De Marchi,
- Paul Theodor Pyl,
- Martin Sjöström,
- Susanne Erika Reinsbach,
- Sebastian DiLorenzo,
- Björn Nystedt,
- Lena Tran,
- Gyula Pekar,
- Fredrik Wärnberg,
- Irma Fredriksson,
- Per Malmström,
- Mårten Fernö,
- Lars Malmström,
- Johan Malmstöm,
- Emma Niméus
Affiliations
- Tommaso De Marchi
- Department of Clinical Sciences Lund, Division of Oncology, Lund University
- Paul Theodor Pyl
- Department of Laboratory Medicine, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory
- Martin Sjöström
- Department of Clinical Sciences Lund, Division of Oncology, Lund University
- Susanne Erika Reinsbach
- Department of Biology and Biological Engineering, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Chalmers University of Technology
- Sebastian DiLorenzo
- National Bioinformatics Infrastructure Sweden, Uppsala University, Science for Life Laboratory, Department of Cell and Molecular Biology
- Björn Nystedt
- National Bioinformatics Infrastructure Sweden, Uppsala University, Science for Life Laboratory, Department of Cell and Molecular Biology
- Lena Tran
- Department of Clinical Sciences Lund, Division of Oncology, Lund University
- Gyula Pekar
- Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital
- Fredrik Wärnberg
- Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg
- Irma Fredriksson
- Department of Molecular Medicine and Surgery, Karolinska Institutet
- Per Malmström
- Department of Clinical Sciences Lund, Division of Oncology, Lund University
- Mårten Fernö
- Department of Clinical Sciences Lund, Division of Oncology, Lund University
- Lars Malmström
- Department of Clinical Sciences Lund, Division of Infection Medicine, Faculty of Medicine, Lund University
- Johan Malmstöm
- Department of Clinical Sciences Lund, Division of Infection Medicine, Faculty of Medicine, Lund University
- Emma Niméus
- Department of Clinical Sciences Lund, Division of Oncology, Lund University
- DOI
- https://doi.org/10.1038/s42003-023-04526-6
- Journal volume & issue
-
Vol. 6,
no. 1
pp. 1 – 14
Abstract
A proteogenomic analysis of matching primary breast cancer and ipsilateral breast tumor recurrence (IBTR) samples provides insight into the development of IBTR and may be useful in identifying biomarkers for IBTR formation.
